12 Results for "

TRIP13

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "TRIP13" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-130603
CAS No.: 2242470-43-3
Purity:  99.81%
Target:  

NF-κB Apoptosis

Research Areas:  

Cancer

DCZ0415, a potent TRIP13 inhibitor, impairs nonhomologous end joining repair and inhibits NF-κB activity. DCZ0415 induces anti-myeloma activity in vitro, in vivo, and in primary cells derived from drug-resistant myeloma patients .
loading...
    loading...
Cat. No.: HY-157331
CAS No.: 2883709-99-5
Purity:  99.02%
Target:  

NF-κB Apoptosis

Research Areas:  

Cancer

DCZ5418 is an inhibitor of TRIP13. DCZ5418 has anti-multiple myeloma activity in vitro and in vivo .
loading...
    loading...
Cat. No.: HY-Q04764
CAS No.: 1005178-02-8
Research Areas:  

Cancer

TI17 is an inhibitor of the thyroid hormone receptor-interacting protein Trip13 and has anticancer activity. TI17 effectively inhibits multiple myeloma (MM) cell proliferation and induces cell cycle arrest and apoptosis. Trip13 is an AAA-ATPase that mediates double-strand break (DSB) repair; TI17 inhibits Trip13 function and increases DNA damage .
loading...
    loading...
Cat. No.: HY-RS15079
Research Areas:  

Others

TRIP13 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIP13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS23601
Research Areas:  

Others

Trip13 Rat Pre-designed siRNA Set A contains three designed siRNAs for Trip13 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS17151
Research Areas:  

Others

Trip13 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Trip13 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-162999
Research Areas:  

Cancer

TRIP13-IN-1 (compound 20) is a potent ligand and inhibitor of TRIP13, demonstrating anti-cancer effects both in vitro and in vivo.
loading...
    loading...
Cat. No.: HY-P990867

Target:  

Insulin Receptor Akt

Research Areas:  

Cancer

Anti-CD220/Insulin Receptor Antibody (IR 83-22) is an anti-human CD220/Insulin Receptor IgG1 monoclonal antibody. Anti-CD220/Insulin Receptor Antibody (IR 83-22) can block Akt overactivation caused by Trip13 deficiency. Anti-CD220/Insulin Receptor Antibody (IR 83-22) can be used for research on cancer such as hepatocellular carcinoma (HCC). Anti-CD220/Insulin Receptor Antibody (IR 83-22) often used in western blotting. The recommend isotype control of Anti-CD220/Insulin Receptor Antibody (IR 83-22): Mouse IgG1 kappa, Isotype Control (HY-P99977) .
loading...
    loading...
Cat. No.: HY-P701866
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: TRIP13; Pachytene checkpoint protein 2 homolog; Human papillomavirus type 16 E1 protein-binding protein; 16E1-BP; HPV16 E1 protein-binding protein; Thyroid hormone receptor interactor 13; Thyroid receptor-interacting protein 13; TR-interacting protein 13; TRIP-13
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P701865
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: TRIP13; Pachytene checkpoint protein 2 homolog; Human papillomavirus type 16 E1 protein-binding protein; 16E1-BP; HPV16 E1 protein-binding protein; Thyroid hormone receptor interactor 13; Thyroid receptor-interacting protein 13; TR-interacting protein 13; TRIP-13
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P88095
Synonyms: 16E1BP

Host:  

Mouse

Application:  

WB, IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P88095A
Synonyms: 16E1BP

Host:  

Mouse

Application:  

WB, IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
  • 1